Glioma Stocks List
Symbol | Grade | Name | % Change | |
---|---|---|---|---|
YMAB | C | Y-mAbs Therapeutics, Inc. | -1.45 | |
CELZ | D | Creative Medical Technology Holdings, Inc. | 1.17 | |
AEZS | D | AEterna Zentaris Inc. | 5.29 | |
KZIA | F | Kazia Therapeutics Limited | -1.24 | |
AGEN | F | Agenus Inc. | 4.24 | |
CLDI | F | Calidi Biotherapeutics, Inc. | -0.48 | |
BDRX | F | Biodexa Pharmaceuticals plc | 88.59 |
Related Industries: Biotechnology
Symbol | Grade | Name | Weight | |
---|---|---|---|---|
CNCR | C | Loncar Cancer Immunotherapy ETF | 3.48 | |
CSML | B | IQ Chaikin U.S. Small Cap ETF | 0.56 | |
BBC | C | Virtus LifeSci Biotech Clinical Trials ETF | 0.55 | |
WDNA | C | WisdomTree BioRevolution Fund | 0.44 | |
BTEC | D | Principal Healthcare Innovators Index ETF | 0.4 |
Compare ETFs
Related Industries:
Biotechnology
- Glioma
A glioma is a type of tumor that starts in the glial cells of the brain or the spine. Gliomas comprise about 30 percent of all brain tumors and central nervous system tumors, and 80 percent of all malignant brain tumors.
Recent Comments
- TraderMike on Market Recap for Friday, March 8, 2024
- Don_Marat on Market Recap for Friday, March 8, 2024
- TraderMike on Trades of the Week: Feb 12 - Feb 16, 2024
- Cos3 on Trades of the Week: Feb 12 - Feb 16, 2024
- SwingTradeBot on Market Recap for Tuesday, February 27, 2024
From the Blog
Featured Articles